Objective: It was aimed to compare the some tumor markers, acute phase proteins, sialic acid and lipid bound sialic acid levels in patients with stomach cancer before and after chemotherapy to the healthy controls Material and Methods: Forthy-eight patients with stomach adenocarcinoma and 20 healthy controls, totally 68 subjects were used. Blood samples were taken from all patients before and after chemotherapy and controls to analyze the levels of tumor markers (CA 125, CA 15-3, CA 19-9, CEA), acute phase proteins (CRP and fibrinogen) and SA (sialic acid), LSA (lipid bound sialic acid).
Introduction
The prevalence of stomach cancer has shown differences among the countries. It is still in the second rank at the cancer deaths in the world despite the clear decrease in its prevalence. The stomach cancer is the most commonly case in Van and its vicinity (1) . Because the stomach cancer is a insidious disease, it is difficult to understand its etiology, there are many studies on the biomarkers or tumor markers to support the diagnosis. Tumor markers which have different characteristics such as glycoprotein and glycolipid show specific features for many organ cancers. They help to diagnose the cancer and also help to estimate the good and poor prognosis of the cancer patients. The origin of marker can even be the ectopic hormon synthesis, oncofetal antigens and the metabolic products of neoplastic cell or the answer of the patient to the tumor development (2) . The qualitative or quantitative chemical, molecular biological or immunologic methods can be used for the diagnosis of cancer.
They are valuable than the other diagnostic tools for determining the early stage of tumor. Today, it was proved that the tumor markers like CEA, CA 15-3, CA 125, CA 19-9 have important places in clinical use for some cancers (3) .
The sialic acid, a monosaccharide with negative charge of 9 carbons, has many functions such as protecting the structures of cell membranes and glycoproteins, cell to cell interactions, membrane transport, binding molecule in membrane receptors, effects in the blood glycoprotein structure, regulating the permeability in basal membrane of glomerules (4) . The abnormal glycosylation process in tumor cells increases the sialic acid level in the surface of malignant and trasformed cells by contributing to the biosynthesis of carbohydrate structure. Some studies showed that cell form, cell stickness and the growth rate affect the sialic acid content of the cell (5) . The ratio of carbohydrate synthesis in the growing cells was found relatively high when compared with the ungrown cell (6) .
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Medical Science and Discovery, 2016; 3(1): Acute phase proteins are mostly synthesized by hepatocytes in response to pro-inflammatory cytokines to tissue injury and infections. CRP, fibrinogen, haptoglobin, complement factors, ceruloplasmin, ferritin and serum amiloid A can be taken into account as acute phase proteins (7) . CRP is produced by liver within 6 hours of an acute inflammation by the direct stimulation of IL-6. It is a pentraxin protein which has Ca-dependent ligand binding. The relation between IL-6 and CRP were shown in various types of cancer. CRP was important in poor cancer prognosis and metastasis (8, 9) . Some researches were found that fibrinogen, blood clotting factor, can be a good tumor marker in pancreas, esophagus and stomach cancers (10) (11) (12) .
In this study, it was aimed (i) to compare the tumor markers, acute phase proteins, sialic acid and lipid bound sialic acid levels of the stomach cancer patients before and after chemotherapy; (ii) to evaluate the importance of sialic acid and lipid bound sialic acid for gastric cancer.
Material and Methods

Patients and Blood Sampling
Totally 48 patients (33 male and 15 female, age of 45-76) diagnosed as stomach cancer in Yuzuncu Yıl University Faculty of Medicine Oncology Clinic and 20 healthy controls (12 male and 8 female, age of 35-64) were chosen to the study. Stomach adenocarcinoma was diagnosed by endoscopic biopsy in all the patients. The cancer were ranked into stages by lung graphy, abdominal computed tomography, biochemistry, hemogram and if needed magnetic resonans. The patients who are in localised stages were excluded from the study because they were chosen for surgical treatment. The advanced local and metastatic cancer patients were chosen to study because they were the candidates for systematic chemotherapy. Blood were taken before starting treatment and then cisplatin and 5-flourouracil based chemotherapy was started orally or intravenously. After it was repeated 3-4 times in two or three weeks, according to the chemotherapy protocols.
Cisplatin-5 FUFA (5Flourouracil-Folinic acid) was given biweekly or cisplatin-UFT (uracil tegafur) was given once in 21 days. Responses of all patients to this chemotherapy were investigated clinically and radiological after 3-4 cures. Chemotherapy protocol is listed in table 1-2.
Blood samples were taken from all patients into the non-anticoagulant and sodium citrate tubes after the chemotherapy. They were centrifuged for 10 minutes in 2500 rpm, sera and plasma were separated.
Measurement of SA, LSA, Tumor Markers and Acute Phase Proteins
The levels of serum SA (13, 14) and LSA (15, 16) were determined spectrophotometrically. The LSA level were calculated by using calibration curve (13) (14) (15) (16) (17) . The serum CA 125, CA 15-3, CA 19-9, CEA tumor marker levels were determined in autoanalyzer with chemiluminescent immunoassay method by using commercial kits (Immulite 2000 DPC, LosAngeles, USA) (18) . The serum CRP measurement was done by nefelometer (Dade Behring, Model BN II) by using hsCRP kit (19, 20) Plasma fibrinogen levels were determined by Clauss Clotting Method with STA Compact (21) .
Statistical analysis:
Statistical analyses were performed using SPSS (SPSS Inc, Chicago IL, USA) version 17.0. The statistical analyses were done by Wilcox Test and Mann Whitney-U Test.
Results
The levels of tumor markers (CA 125, CA 15-3, CA 19-9 and CEA), SA, LSA and the acute phase proteins (CRP and fibrinogen) of the stomach cancer patients and the controls before and after chemotherapy are shown in Table 3 .
The levels of CA 125, CA 15-3, CA 19-9, CEA, SA, LSA, CRP and fibrinogen were found higher than the controls. They were declined after the chemotherapy but still high. As seen in table 3, there were statistical importances among the groups.
While serum level of CA 125 was found as 107.30 U/ml before chemotherapy and diminished to 36.46 U/ml after chemotherapy. The serum level of CA 125 of the control group was found as 8.64 U/ml.
The serum levels of CA 15-3 before chemotherapy in stomach cancer patients were higher (65.74-21.65 U/ml) than that of both the controls and after chemotherapy.
While the serum levels of CA 19-9 in stomach cancer patients were found higher compared than that of the controls (295.86-21.52 U/ml; p<0.05), this value was dropped to100.18 U/ml after chemotherapy and found as statistically important compared to before chemotherapy (p<0.05).
Before and after chemotherapy serum levels of CEA were found statistically high p<0.001 and p<0.01, respectively when compared to the controls. After chemotherapy serum levels of CEA (20.20 ng/ml) were found statistically low (p<0.01), when compared to before chemotherapy (108.57 ng/ml).
It was determined that the serum levels of SA were higher significantly (199.60 mg/dl-73.75 mg/dl; p<0.001) before chemotherapy when compared to the controls. While the level of SA was statistically lower after chemotherapy (87.67 mg/dl) compared to before chemotherapy groups. The serum levels of LSA were elevated significantly (41.89 mg/dl-27.47 mg/dl) before chemotherapy when compared after chemotherapy and control group. The level of LSA was significantly reduced after chemotherapy (31.06 mg/dl) when compared to before chemotherapy groups and the controls (p<0.01).
The level of CRP was higher before chemotherapy (86.03 mg/l-2.37 mg/l; p<0.001) compared to the controls. Despite that it decreased down to 57.04 mg/l after chemotherapy, it still remained statistically higher when compare to the controls. The levels of fibrinogen were 469.42 mg/dl and 379.04 mg/dl before and after chemotherapy. Significantly differences were found between the groups.
Discussion
Cancer is one of the severe disease cause death and mostly diagnosed at the latest stage or during metastasis. Therefore, early diagnosis is an important factor for the treatment and prognosis. CEA ve CA 19-9 and CA 125 can be used for the prediction of the stage and prognosis of the cancer (22, 23).
Yamamoto et al. (24) stated that CEA diagnosed and predicted the peritonal spread better than CA 125 ve CA 19-9 in stomach cancers which show peritonal spread. Takahashi (25) emphasized that CEA and/or CA 19-9 is the important biomarkers for observing the recurrence probability of stomach cancer after the operation. Webb et al. (26) stated that CEA ≥5 mg/l and CA 125 ≥ 350 U/l reflect the poor prognosis in In the presented study, four different tumor markers (CA 125, CA 15-3, CA 19-9 and CEA) were measured in pre and post-treatment at stomach cancer patients and compared with the healthy controls. These tumor marker levels were determined higher before chemotherapy in stomach cancer patients. It was still found higher even there was a decrease in ongoing post-treatment level while the levels of the tumor markers were decreased following the chemotherapy. It can indicate the effectiveness of the treatment, positive improvement in prognosis and the extention of the patients' life time .
The tumor cells have got different surface charasteristics compared to the normal cells which were partly resulted from sialoglycoconjugate. The behaviors and metastatic characteristics of the cells are affected by them. The sialic acid level in malign cell surface is related with metastasis (5). Many researchers determined that total and lipid bounded sialic acid levels increased in different cancer types (27, 28) . It is known that the sialic acid is necessary for cell adhesion and carries out the electrostatic impulse in thrombocyte, cancer cells and erythrocytes via the negative charge (29) .
The high level of serum SA and LSA can originate from increased synthesis or sialic acid release which is found on the cell surface glycoconjugate (30) . Furthermore, it was suggested that the sialic acid concealed the tumor cells or tumor specific antigens from the immunological attack, and protected the invasion and metastatic characters of malignant cells (31) .
Total serum sialic acid levels increases in stomach cancer patients (32) . A positive correlation was found between stage of cancer, metastasis grade and sialic acid level. The high serum sialic acid level shows poor prognosis (28, 33) . While Krasnodebski (34) put negative opinion for the biomarker probability of sialic acid level because of its 55.2 % sensitivity, the increased serum SA level in metastasis supports the metastatic cell existance.
As it can be seen in this study that SA and LSA levels increased in stomach cancer cases and decreased after chemotherapy. The increased levels of SA and LSA in stomach cancer were compatible with the previous literatures. The increased serum levels of SA and LSA in malignant cases must be carefully evaluated owing to the levels of them can be rised in some other diseases. Therefore, SA and LSA should be interpreted with the other markers and acute phase proteins. However, Raval et al. (35) reported that high level of SA is a sign of weak or poor prognosis of oral cavity cancer.
In other study, CRP and cytokine levels were investigated in stomach cancer patients. A correlation was found between poor prognosis and systemic inflammation. Furthermore, CRP was also related with the decrease of the patients' life span (36). Wu et al. (37) indicated that there was a moderate correlation between CRP and increased cytokine levels in stomach cancer.
Fukata et al. (38) determined that CRP level in liver cancer patients with stomach metastasis and also reported that the level of CRP was decreased following the gastrectomy. Tavaris et al. (39) evaluated the levels of CRP, transferrin, α-2 macroglobulin, ceruloplasmin, α-1 acide glycoprotein, retinol binding protein and prealbumin in 153 stomach cancer patients before surgical operation. The level of CRP was clearly higher in patients than the controls but any differences were not found in other parameters (39) . It was concidered that CRP was more sensitive than the other acute phase proteins in cancer patients.
In this study, levels of CRP were found as 2.37 -86.03 -57.04 mg/l in all three groups (control, pretreatment and post-treatment), respectively. The main reason of the high CRP level in stomach cancer patients is the stimulation of CRP synthesis by cytokine response to the cancer formation. The major inducer of CRP synthesis is IL-6. Likewise, Iijima et al. (40) stated that the high level of IL-6 was found in stomach cancer patients. In addition, CRP is the fastest responder of the acute phase proteins during the infection.
The high plasma fibrinogen level was found usually in malignant diseases. However, Di Micco et al. (41) showed that the fibrinogen level increased in 11 nonmetastatic stomach cancer. Some studies have been done to explain the relationship between the plasma fibrinogen levels and tumor size, invasion depth and metastasis (42) . While the hyperfibrinogenemia was related with cancer progression and metastasis, the low level of fibrinogen was a sign of weak metastasis (43) . Yamashita et al. (12) evaluated the CEA, CRP and fibrinogen levels in the 649 operated patients with stomach cancer. They proposed that hyperfibrinogenemia could provide favorable circumstances for cancer cells to metastasize via the lymphatic system. The plasma level of preoperative fibrinogen could be a useful predictor of lymphatic metastasis in patients with intestinal-type gastric cancer.
Yamamura et al. (44) observed that fibrinogen activity was decreased in stomach cancer patients after total stomach resection. Brajerzki et al. (45) measured the plasma level of fibrinogen in patients with stomach cancer and ulcer. They could not determine any increase of fibrinogen in patients with ulcer but there was a high increase in 67% of cancer patients. Some hematological parameters such as fibrinogen, Medical Science and Discovery, 2016; 3(1): 22-7 thrombocyte, hematocrit were investigated in 63 cancer patients, and all parameters in cancer patients were higher than the controls (46) .
In this study, the fibrinogen level showed significant increase in pre-treatment group compared to the other two groups. The values of fibrinogen levels were at normal margins because the laboratory measurement intervals were 300-400 mg/dl. Our results with regard to fibrinogen level were compatible with investigated literatures. Likewise, Wang et al. (47) recommended that fibrinogen was related with cancer diagnose and prognose like the other parameters.
Conclusion
As a consequence, significant increases were determined in the serum levels of CA 125, CA 15-3, CA 19-9, CEA, SA, LSA, CRP and fibrinogen of patients with stomach cancer. It is strongly emphasized that SA and LSA may be considered as tumor markers, and also acute phase proteins such as CRP and fibrinogen should be used for diagnosis and prognosis in patients with stomach cancer before and after chemotherapy.
